171 related articles for article (PubMed ID: 37123205)
1. Inhibition of phosphoinositide‑3 kinases γ/δ ameliorates pulmonary granuloma by rescuing Treg function in a sarcoidosis model.
Zhang X; Dai Q; Shan J; Zhang S; Zhang B; Liu S; Zhang Y; Wang Y; Li X; Jin X; Liang D; Ding J; Wang Y; Wen Y
Exp Ther Med; 2023 May; 25(5):225. PubMed ID: 37123205
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 33 ameliorates disturbance of regulatory T cells in pulmonary sarcoidosis.
Zhang B; Zhao F; Mao H; Ma W; Zhang Y; Zhang X; Ding J; Gao Q; Wen Y
Int Immunopharmacol; 2018 Nov; 64():208-216. PubMed ID: 30195819
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide 3-kinase/protein kinase B inhibition restores regulatory T cell's function in pulmonary sarcoidosis.
Zhang B; Dai Q; Jin X; Liang D; Li X; Lu H; Liu Y; Ding J; Gao Q; Wen Y
J Cell Physiol; 2019 Nov; 234(11):19911-19920. PubMed ID: 30945303
[TBL] [Abstract][Full Text] [Related]
4. Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin-induced diabetes.
Zhang S; Dai Q; Zhang B; Liu S; Wang Y; Zhang Y; Chen D; Zong N; Wang H; Ding J; Gao Q; Wen Y
Ann Transl Med; 2021 Nov; 9(22):1642. PubMed ID: 34988151
[TBL] [Abstract][Full Text] [Related]
5. Anti-TL1A monoclonal antibody modulates the dysregulation of Th1/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K/AKT signaling pathway.
Ma C; Huang J; Zheng Y; Na Y; Wei J; Shan J; Meng K; Zhang X; Zhang S; Wen Y; Ding J
Int Immunopharmacol; 2024 Jun; 137():112360. PubMed ID: 38852524
[TBL] [Abstract][Full Text] [Related]
6. Extensively disturbance of regulatory T cells - Th17 cells balance in stage II pulmonary sarcoidosis.
Ding J; Dai J; Cai H; Gao Q; Wen Y
Int J Med Sci; 2017; 14(11):1136-1142. PubMed ID: 29104468
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A/anti-CCL20 induced the rebalance of Th17/regulatory T cells in SodA-induced sarcoidosis.
Meng K; Zhang B; Ma C; Dai Q; Gui X; Liu X; Zhao Q; Gao Q; Wen Y; Ding J
Int Immunopharmacol; 2022 Aug; 109():108784. PubMed ID: 35461156
[TBL] [Abstract][Full Text] [Related]
8. PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.
Hanna BS; Roessner PM; Scheffold A; Jebaraj BMC; Demerdash Y; Öztürk S; Lichter P; Stilgenbauer S; Seiffert M
Leukemia; 2019 Jun; 33(6):1427-1438. PubMed ID: 30573773
[TBL] [Abstract][Full Text] [Related]
9. The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function.
Chellappa S; Kushekhar K; Munthe LA; Tjønnfjord GE; Aandahl EM; Okkenhaug K; Taskén K
J Immunol; 2019 Mar; 202(5):1397-1405. PubMed ID: 30692213
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of regulatory T cells in pulmonary sarcoidosis.
Kachamakova-Trojanowska N; Jazwa-Kusior A; Szade K; Kasper L; Soja J; Andrychiewicz A; Jakiela B; Plutecka H; Sanak M; Jozkowicz A; Sladek K; Dulak J
J Autoimmun; 2018 Nov; 94():56-69. PubMed ID: 30049532
[TBL] [Abstract][Full Text] [Related]
11. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
Yates J; Rovis F; Mitchell P; Afzali B; Tsang J; Garin M; Lechler RI; Lombardi G; Garden OA
Int Immunol; 2007 Jun; 19(6):785-99. PubMed ID: 17545278
[TBL] [Abstract][Full Text] [Related]
12. Th17-lineage cells in pulmonary sarcoidosis and Löfgren's syndrome: Friend or foe?
Miedema JR; Kaiser Y; Broos CE; Wijsenbeek MS; Grunewald J; Kool M
J Autoimmun; 2018 Feb; 87():82-96. PubMed ID: 29310925
[TBL] [Abstract][Full Text] [Related]
13. Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.
Swaisgood CM; Oswald-Richter K; Moeller SD; Klemenc JM; Ruple LM; Farver CF; Drake JM; Culver DA; Drake WP
Am J Respir Cell Mol Biol; 2011 Feb; 44(2):166-74. PubMed ID: 20348207
[TBL] [Abstract][Full Text] [Related]
14. FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions.
Taflin C; Miyara M; Nochy D; Valeyre D; Naccache JM; Altare F; Salek-Peyron P; Badoual C; Bruneval P; Haroche J; Mathian A; Amoura Z; Hill G; Gorochov G
Am J Pathol; 2009 Feb; 174(2):497-508. PubMed ID: 19147826
[TBL] [Abstract][Full Text] [Related]
15. Dose-Dependent Suppression of Cytokine production from T cells by a Novel Phosphoinositide 3-Kinase Delta Inhibitor.
Way EE; Trevejo-Nunez G; Kane LP; Steiner BH; Puri KD; Kolls JK; Chen K
Sci Rep; 2016 Jul; 6():30384. PubMed ID: 27461849
[TBL] [Abstract][Full Text] [Related]
16. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
[TBL] [Abstract][Full Text] [Related]
17. Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.
Uehara M; McGrath MM; Ohori S; Solhjou Z; Banouni N; Routray S; Evans C; DiNitto JP; Elkhal A; Turka LA; Strom TB; Tullius SG; Winkler DG; Azzi J; Abdi R
Nat Commun; 2017 Oct; 8(1):951. PubMed ID: 29038423
[TBL] [Abstract][Full Text] [Related]
18. The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.
Maharaj K; Powers JJ; Achille A; Mediavilla-Varela M; Gamal W; Burger KL; Fonseca R; Jiang K; Miskin HP; Maryanski D; Monastyrskyi A; Duckett DR; Roush WR; Cleveland JL; Sahakian E; Pinilla-Ibarz J
Blood Adv; 2020 Jul; 4(13):3072-3084. PubMed ID: 32634240
[TBL] [Abstract][Full Text] [Related]
19. Activated PI3Kδ Specifically Perturbs Mouse Regulatory T Cell Homeostasis and Function Leading to Immune Dysregulation.
Singh AK; Al Qureshah F; Drow T; Hou B; Rawlings DJ
J Immunol; 2024 Jun; ():. PubMed ID: 38829130
[TBL] [Abstract][Full Text] [Related]
20. Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.
Rao VK; Webster S; Dalm VASH; Šedivá A; van Hagen PM; Holland S; Rosenzweig SD; Christ AD; Sloth B; Cabanski M; Joshi AD; de Buck S; Doucet J; Guerini D; Kalis C; Pylvaenaeinen I; Soldermann N; Kashyap A; Uzel G; Lenardo MJ; Patel DD; Lucas CL; Burkhart C
Blood; 2017 Nov; 130(21):2307-2316. PubMed ID: 28972011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
